Case Study in How to Eliminate Adverse Events, Improve Patient Safety, and Reduce Healthcare Costs

St. Joseph’s/Candler Hospitals reduced opioid-related events with patient-controlled analgesia (PCA) pumps. The hospitals are “error-free” since using “smart” PCA pumps with integrated capnography.

by Michael Wong, JD (Executive Director, Physician-Patient Alliance for Health & Safety)

St. Joseph’s/Candler Hospitals (SJ/C) in Savannah, Georgia, are two of the oldest continuously operating hospitals in the US. About 10 years ago, SJ/C had three opioid-related events with patient-controlled analgesia (PCA) with serious outcomes over a two-year period.

Fortunately, none of these adverse events resulted in deaths, says Carolyn Williams, RPh, Medication Safety Specialist at SJ/C.

Since using “smart” PCA pumps with integrated capnography, SJ/C has been “error-free”. As they report in their article, “Excellent Return on Investment with Capnography Monitoring” in the recent edition of the APSF Newsletter, these changes averted 450 highest-risk IV medication errors and respiratory monitoring helped avert at least 35 PCA-related undesirable events.

PCA pump with integrated capnography like that used at St. Joseph/Candler

Moreover, although a human life should never be measures in dollars and cents, SJ/C calculated that their decision made great financial sense:

  • $4 million — estimated potential expenses averted (not including potential litigation costs)
  • $2.5 million — 5-year return on investment

However, before making the decision to monitor their patients using PCA with capnography, SJ/C conducted a 6-month beta test. This beta test demonstrated the risk of the common practice of triaging patients as a way to determine who was and who was not likely to have opioid-related respiratory depression.

As Williams explains:

Beta testing revealed the difficulty of predicting which patients actually were high-risk, and that capnography, not pulse oximetry, provided the first indication of opioid-related respiratory depression. As a result, the decision was made to require a capnography module for each PCA infusion and to use a pulse oximetry module for selected patients receiving PCA analgesics who have preexisting co-morbidities.

Detecting at the earliest possible time that onset of respiratory depression, which can lead to death, is critical and has great benefit for hospital staff and their ability to provide optimal care and see more patients. Says Williams:

At each shift, the respiratory status of PCA patients is assessed by a therapist. The assessment includes an evaluation of the recorded trend analysis of RR, EtCO2 waveforms, and any pulse oximetry results. Nurses consult respiratory therapists to assist with the assessment at any time during the shift when alarms indicate potential patient respiratory distress. Early identification of respiratory depression allows respiratory therapy to intervene before a patient’s condition becomes serious, which saves time, helps increase the likelihood of a positive outcome, and allows existing staff to oversee more patients.

Consequently, Williams recommends that all patients using PCA be continuously electronically monitored:

Our experience suggests that the use of capnography monitoring on ALL patients who receive PCA can reduce the incidence of adverse events from IV opioids in the postoperative setting.

Leave a Comment, if You Care About Patient Safety